SCHEMBL4114430

SCHEMBL4114430

CC(C)(C)c1cc(N2C(=O)N(Cc3ccc(F)cc3Nc3ccc(C(=O)O)cc3)C(C)(C)C2=O)ccn1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 14/20 0.40
AURKA O14965 2/20 0.39
TAS2R8 Q9NYW2 3/20 0.38
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3528116 0.99 IGF1R (0.39) IGF1RAURKATAS2R8AR
SCHEMBL13254917 0.92 TAS2R8 (0.38) IGF1RTAS2R8
Trifluoroacetic Acid SCHEMBL3525656 0.90 IGF1R (0.38) IGF1RAURKATAS2R8AR
SCHEMBL3527116 0.82 AR (0.54) TAS2R8AR
SCHEMBL3528563 0.82 AR (0.46) AR
SCHEMBL1973106 0.80 IGF1R (0.41) IGF1RAURKATAS2R8
SCHEMBL3526742 0.79 IGF1R (0.43) IGF1RTAS2R8AR
SCHEMBL3525161 0.79 AR (0.41) AR
SCHEMBL3525538 0.79 AR (0.53) AR
SCHEMBL3530989 0.78 AR (0.40) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061767-B1 Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use SANOFI SA (FR) 2014-12-17 EP disclosed
EP-2061767-A1 ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE Sanofi-Aventis (FR) 2009-05-27 EP disclosed
WO-2008017381-A1 ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE SANOFI-AVENTIS (FR) 2008-02-14 WO disclosed